BGLC BioNexus Gene Lab Corp

Nasdaq bionexusgenelab.com


$ 4.46 $ 0.00 (0 %)    

Monday, 17-Nov-2025 09:31:24 EST
QQQ $ 609.32 $ 3.19 (0.53 %)
DIA $ 471.08 $ 0.22 (0.05 %)
SPY $ 671.35 $ 1.62 (0.24 %)
TLT $ 89.28 $ 0.20 (0.22 %)
GLD $ 374.33 $ 0.33 (0.09 %)
$ 4.53
$ 4.52
$ 4.36 x 100
$ 4.61 x 100
-- - --
$ 2.01 - $ 15.60
14,671
na
8.14M
$ 1.01
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-14-2025 09-30-2025 10-Q
2 08-18-2025 06-30-2025 10-Q
3 05-15-2025 03-31-2025 10-Q
4 04-15-2025 12-31-2024 10-K
5 11-15-2024 09-30-2024 10-Q
6 08-14-2024 06-30-2024 10-Q
7 05-15-2024 03-31-2024 10-Q
8 04-16-2024 12-31-2023 10-K
9 11-20-2023 09-30-2023 10-Q
10 08-16-2023 06-30-2023 10-Q
11 05-09-2023 03-31-2023 10-Q
12 03-31-2023 12-31-2022 10-K
13 11-14-2022 09-30-2022 10-Q
14 08-15-2022 06-30-2022 10-Q
15 05-16-2022 03-31-2022 10-Q
16 04-06-2022 12-31-2021 10-K
17 11-15-2021 09-30-2021 10-Q
18 08-12-2021 06-30-2021 10-Q
19 05-18-2021 03-31-2021 10-Q
20 03-30-2021 12-31-2020 10-K
21 11-09-2020 09-30-2020 10-Q
22 11-03-2020 09-30-2020 10-Q
23 08-11-2020 06-30-2020 10-Q
24 05-08-2020 03-31-2020 10-Q
25 03-31-2020 12-31-2019 10-K
26 11-14-2019 09-30-2019 10-Q
27 08-09-2019 06-30-2019 10-Q
28 05-15-2019 03-31-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 bionexus-enters-into-definitive-agreements-with-fidelion-and-tongshu-to-commercialize-vitaguard-tumor-nave-liquid-biopsy-platform-for-minimal-residual-disease

BioNexus Gene Lab Corp. ("BGLC, ("BGLC," NASDAQ:BGLC) today announced it has entered into definitive agreements wit...

 bionexus-gene-lab-files-100m-shelf-registration-and-establishes-20m-atm-program-to-support-growth-in-precision-oncology-and-gene-based-technologies

BioNexus Gene Lab Corp. (NASDAQ:BGLC) ("BioNexus" or the "Company"), a biotechnology company advancing precisio...

 bionexus-gene-lab-files-for-mixed-shelf-of-up-to-100m

-SEC Filing

 bionexus-gene-enters-partnership-with-birchbiomed-to-lead-birchs-10m-funding-round-through-equity-investment-collaboration

BioNexus Gene Lab Corp (NASDAQ:BGLC, "BGLC", or the "Company")), today announced that it has entered into a non...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION